Cannapharmarx, Inc. SEC filings CPMD
Cannapharmarx, Inc. has 365 filings in SEC EDGAR's recent list, going back to Jun 10, 1999. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 13, 2026 (officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 4, 2022 | Sep 28, 2022 |
| PRE 14A | Preliminary proxy statement | Aug 26, 2022 | Aug 25, 2022 |
| DEF 14A | Proxy statement | Jun 29, 2020 | Jul 31, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 21, 2019 |
| DEF 14C | Information statement | Dec 18, 2018 | Dec 18, 2018 |
| PRE 14C | Form pre14c | Dec 6, 2018 | Dec 5, 2018 |
| DEFA14A | Additional proxy material | Aug 24, 2015 | — |
| DEF 14A | Proxy statement | Jul 17, 2015 | Aug 28, 2015 |
| DEF 14A | Proxy statement | Nov 21, 2014 | Nov 21, 2014 |
| DEF 14A | Proxy statement | Oct 9, 2014 | Oct 8, 2014 |
| PRE 14A | Preliminary proxy statement | Sep 26, 2014 | Sep 26, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 6, 2008 | Oct 3, 2008 |
| DEF 14A | Proxy statement | Apr 14, 2008 | Apr 14, 2008 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2008 | Mar 18, 2008 |
| DEF 14A | Proxy statement | Apr 27, 2000 | May 30, 2000 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CPMD (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mountain View County
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1081938
- Former names
- GOLDEN DRAGON HOLDING CO. (until Oct 27, 2014); CCVG, INC. (until Jan 12, 2011); CONCORD VENTURES, INC. (until Nov 17, 2010); CAVION TECHNOLOGIES INC (until Jul 25, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.